← Leaderboards
Emily Toth Martin
Wayne State University
$8,572,101
Attributed
$10,392,271
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.7M · FY2012–25$5M$3.8M$2.5M$1.3M$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
CDC$6,110,622 · 1
NIH$4,281,649 · 2
By mechanism
U01$6,110,622 · 1
R01$3,640,340 · 1
K01$641,309 · 1
Top collaborators
- Adam Lauring5 shared
Most similar at Wayne State University
Same institution · by research overlap
- Paul C. Roberts$1,370,009
- June Kan-Mitchell$7,407,089
- Jie Xu$7,149,926
- Peng George Wang$11,974,279
- David Oupicky$10,225,505
Others in their field
Top investigators on “Publishing”
- Constance Ann Benson · University Of California, San Diego$243,271,751
- Richard K. Wilson · Washington University$201,137,538
- Norman Wolmark · Nsabp Foundation, Inc.$139,047,706
- Judith S. Currier · University Of California Los Angeles$137,892,773
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$137,892,773
- Peter C Adamson · National Childhood Cancer Foundation$108,407,802
Research focus
PublishingInfectionNational Institute Of Allergy And Infectious DiseaseEpidemiologyIntegration Host FactorsCharacteristicsMolecularFoundationsTransmission ProcessAffectPersonsPublic HealthAntibody Titer MeasurementHazardAntibodiesCommunity-Acquired InfectionsGenetic VariationHazard ModelsCommunicable DiseasesFlu TransmissionCohortCommunitiesEvolutionClinical Data
Grant awards (14)
RFA-IP-22-004:Michigan-Ford Initiative to Measure Vaccine Effectiveness (MFIVE): Seasonal Influenza, COVID-19 and Respiratory Virus Vaccines$1,310,713
U01 · FY2025 · IP · contact PI
RFA-IP-22-004:Michigan-Ford Initiative to Measure Vaccine Effectiveness (MFIVE): Seasonal Influenza, COVID-19 and Respiratory Virus Vaccines$1,400,000
U01 · FY2024 · IP · contact PI
Evolution and Transmission of Influenza Virus in Natural Human Infection$672,995
R01 · FY2024 · AI
RFA-IP-22-004, Michigan-Ford Initiative to Measure Vaccine Effectiveness (MFIVE): Seasonal Influenza, COVID-19 and Respiratory Virus Vaccines$1,400,000
U01 · FY2023 · IP · contact PI
Evolution and Transmission of Influenza Virus in Natural Human Infection$726,987
R01 · FY2023 · AI
Michigan-Ford Initiative to Measure Vaccine Effectiveness (MFIVE): Seasonal Influenza, COVID-19 and Respiratory Virus Vaccines$1,999,909
U01 · FY2022 · IP · contact PI
Evolution and Transmission of Influenza Virus in Natural Human Infection$746,786
R01 · FY2022 · AI
Evolution and Transmission of Influenza Virus in Natural Human Infection$746,786
R01 · FY2021 · AI
Evolution and Transmission of Influenza Virus in Natural Human Infection$746,786
R01 · FY2020 · AI
Defining Precursors to VRSA Emergence: Epidemiology of MRSA & VRE Dual Infection$128,025
K01 · FY2016 · AI · contact PI
Defining Precursors to VRSA Emergence: Epidemiology of MRSA & VRE Dual Infection$128,321
K01 · FY2015 · AI · contact PI
Defining Precursors to VRSA Emergence: Epidemiology of MRSA & VRE Dual Infection$128,321
K01 · FY2014 · AI · contact PI
Defining Precursors to VRSA Emergence: Epidemiology of MRSA & VRE Dual Infection$128,321
K01 · FY2013 · AI · contact PI
Defining Precursors to VRSA Emergence: Epidemiology of MRSA & VRE Dual Infection$128,321
K01 · FY2012 · AI · contact PI